Finance

Lists
BIOV:CNSX
Biovaxys Technology Corp
0,070 CA$
0,00%
(0,00) 1D
5 мам., 15:55:53 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Mkt. cap
3,09 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CA$
52-wk low
0,03 CA$
Mkt. cap
3,09 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CA$
52-wk low
0,03 CA$
News stories
From web sources and news partners
About Biovaxys Technology Corp
CEO-
Employees-
Founded-
HeadquartersТоронто, Онтарио, Канада
SectorPharmaceutical industry
Websitebiovaxys.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2024 ж. қаз.
2025 ж. қаң.
2025 ж. сәу.
2025 ж. шіл.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,50 мың
32,95 мың
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,20 млн
1,03 млн
1,08 млн
859,08 м.
Operating expense
1,49 млн
1,14 млн
1,22 млн
859,08 м.
Total operating expenses
1,49 млн
1,14 млн
1,22 млн
859,08 м.
Operating income
-1,49 млн
-1,14 млн
-1,22 млн
-859,08 м.
Other non operating income
-8,90 мың
-68,18 мың
-67,98 мың
-50,97 мың
EBT including unusual items
-2,74 млн
-1,07 млн
-1,32 млн
-910,06 м.
EBT excluding unusual items
-1,50 млн
-1,25 млн
-1,30 млн
-910,06 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,74 млн
-1,07 млн
-1,32 млн
-910,06 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары